ClearSign Technologies Corp (CLIR): Nasdaq/NYSE listing notice — ClearSign gets Nasdaq bid price deficiency notice; Maley appointed to committees

ClearSign Technologies Corp

Received Nasdaq notice on May 2, 2024 for closing bid price below $1 for 30 consecutive business days.
Company has 180-day cure period ending October 29, 2024; must close at $1 for 10 consecutive days.
If not cured, may seek additional 180-day period with reverse stock split if eligible.
Independent director David M. Maley appointed to Nominating and Governance Committee and Compensation Committee, effective May 3, 2024.
Company will monitor bid price and consider options; no assurance of regaining compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ClearSign Technologies Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

May 2, 2024, ClearSign Technologies Corporation (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days beginning on March 20, 2024 and ending on May 1, 2024, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a perio

View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ClearSign Technologies Corp filing history →

Source: SEC EDGAR

accession 0001104659-24-057077

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.